DaBomb Protein Biotech Corp. (6578.TWO)

TWD 19.2

(-2.54%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 384.41 Million 433.63 Million 470.62 Million 605.22 Million 646.59 Million
Cost of Revenue 337.98 Million 414.3 Million 448.97 Million 505.95 Million 521.99 Million
Gross Profit 46.42 Million 19.32 Million 21.65 Million 99.27 Million 124.6 Million
Operating Expenses 76.35 Million 81.8 Million 85.42 Million 83.88 Million 85.47 Million
Selling, General and Administrative Expenses 62.76 Million 69.94 Million 73.6 Million 69.73 Million 74.19 Million
Research and Development Expenses 13.59 Million 11.85 Million 11.81 Million 14.14 Million 11.28 Million
Other Expenses - 17.62 Million -5.7 Million -2.84 Million -
Cost and Expenses 414.34 Million 496.1 Million 534.4 Million 589.83 Million 607.47 Million
Operating Income -29.93 Million -42.47 Million -67.04 Million 14.22 Million 39.12 Million
Interest Expense 8.23 Million 6.57 Million 4.57 Million 2.59 Million 1.3 Million
Income Tax Expense 1.07 Million -4.39 Million -9.17 Million 4.43 Million 10.51 Million
Earnings before Tax -55.94 Million -49.05 Million -71.61 Million 11.63 Million 31.7 Million
Net Income -57.02 Million -44.66 Million -62.44 Million 7.19 Million 21.19 Million
Earnings Per Share Basic -1.07 -1.15 -1.92 0.22 0.65
Earnings Per Share Diluted -1.07 -1.15 -1.92 0.22 0.64
Weighted Average Shares Outstanding 53.5 Million 38.69 Million 32.47 Million 32.94 Million 32.81 Million
Weighted Average Shares Outstanding (Diluted) 53.5 Million 38.69 Million 32.47 Million 33.16 Million 33.06 Million
Gross Margin 0.12 0.04 0.05 0.16 0.19
EBIT Margin -0.07 -0.04 -0.09 0.07 0.08
Profit Margin -0.15 -0.10 -0.13 0.01 0.03
EBITDA -25.99 Million -15.49 Million -40.8 Million 39.82 Million 49.91 Million
Earnings Before Tax Margin -0.08 -0.10 -0.14 0.02 0.06

Income Statement Charts